This tool is intended to facilitate the calculation of the number of infections and other health outcomes averted, and the associated savings in direct medical costs and productivity costs, by STI prevention program activities as described in this User Guide and supporting scientific manuscript and appendix.
This report evaluates the current needs, protocols, and promising practices for latent tuberculosis infection (LTBI) and tuberculosis (TB) screening, testing, and treatment among community health centers serving Asian American/Asian (A/AA) and Native Hawaiian/Pacific Islander (NH/PI) populations.
This report summarizes the TB Elimination Alliance's (TEA) activities and outcomes from 2019 to 2024.
This webpage explains Assembly Bill 2132, which mandates tuberculosis (TB) risk assessment and testing for adult primary care patients in California.
This information sheet outlines how the Pennsylvania Department of Health improved STI treatment reporting by partnering with REDCap to streamline its PA-NEDSS system. It highlights key steps and considerations for jurisdictions aiming to enhance data quality or implement new reporting programs.
This journal article shows that Syphilis incidence has increased significantly in the US, raising concerns about onward transmission. Using near-real-time data, this study examined monthly trends in syphilis incidence among US adults from January 2017 to October 2024, focusing on overall patterns and stratifying by demographic and clinical characteristics.
This Maine CDC handout explains Expedited Partner Therapy (EPT) for chlamydia, detailing medication use, precautions, and the importance of abstaining from sex for seven days post-treatment to prevent reinfection.
This module is designed to introduce student providers to the most common sexually transmitted infections (STI) in the region and indications for screening/testing. Careful consideration of patient history, current symptoms, and local STI rates will allow the student to select efficient laboratory testing to reduce time to treatment and unnecessary testing. This module will provide a basic understanding of the timing and interpretation of serological, molecular, and microscopic screening for patients who have contracted, currently or in the past, an STI.
This module is the third installment in the Sexually Transmitted Infections (STI) series and will focus on treatment of the most common treatable STIs in the United States, including syphilis, gonorrhea, chlamydia, and trichomoniasis. Students will virtually interact with simulated patients to learn how to interpret STI testing results, select the appropriate guideline-directed treatment option, and practice counseling patients regarding STI treatment. This module will help prepare students to treat patients in the RESPECT clinic and in clinical practice.
This fact sheet addresses common questions about insurance coverage for viral hepatitis prevention and treatment services. It outlines coverage details for hepatitis A and B vaccinations, hepatitis B and C screenings, and treatments across various insurance types, including Medicaid, Medicare, and private plans.
